Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
Status:
Not yet recruiting
Trial end date:
2026-07-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety, tolerability, PK, and efficacy of
INCB 99280 in combination with ipilimumab in participants with select solid tumors.